Corvus Pharmaceuticals, Inc.CRVSNASDAQ

Revenue (LTM)

Net Income (LTM)

$-15M

+75.5% YoY

Free Cash Flow

$-33M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-39	-33↑15.7%	-23↑28.1%	-28↓17.7%	-43↓56.0%
Net Income	-43	-41↑4.5%	-27↑34.6%	-62↓130.5%	-15↑75.5%
EBITDA	-38	-32↑15.6%	-23↑27.8%	-27↓18.1%	-43↓56.5%
EPS Diluted	-1.03	-0.89↑13.6%	-0.56↑36.8%	-1.02↓81.2%	-0.53↑48.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	63	13↓79.3%	13↓4.1%	9↓30.7%	5↓47.6%
Total Current Assets	71	44↓38.8%	28↓36.0%	54↑94.6%	58↑7.0%
Total Assets	109	68↓37.7%	46↓33.2%	69↑51.3%	71↑3.2%
Total Current Liabilities	10	11↑10.9%	7↓36.1%	35↑415.4%	9↓73.5%
Total Liabilities	12	12↓1.4%	7↓43.3%	36↑429.0%	10↓72.7%
Total Equity	97	56↓42.2%	39↓31.1%	33↓15.8%	61↑87.9%
Total Debt	4	3↓28.7%	1↓47.2%	1↓18.3%	1↓16.5%
Net Debt	-60	-11↑82.3%	-11↓6.5%	-8↑32.3%	-4↑52.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-37	-27↑26.4%	-24↑11.4%	-25↓6.2%	-33↓29.0%
Capital Expenditure	-0	-0↓5280.0%	-0↑87.4%	0	-0
Free Cash Flow	-37	-27↑25.7%	-24↑12.2%	-25↓6.1%	-33↓29.7%
Stock-Based Comp	4	3↓36.4%	2↓20.2%	3↑39.9%	5↑77.5%
Net Change in Cash	47	-50↓207.0%	-1↑98.9%	-4↓619.9%	-4↓7.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance